Report cover image

Global Flunixin Meglumine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 197 Pages
SKU # APRC20356495

Description

Summary

According to APO Research, The global Flunixin Meglumine Injection market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Flunixin Meglumine Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Flunixin Meglumine Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Flunixin Meglumine Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Flunixin Meglumine Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Flunixin Meglumine Injection include Wuhan Huisheng Biological Technology Co., Ltd., Shandong Zhongmu Veterinary Medicine Co., Ltd., Shandong Lukang Pharmaceutical Co., Ltd., Qilu Animal Health Products Co., Ltd., Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd., Hebei New Century Pharmaceutical Co., Ltd., Baimukang Animal Pharmaceutical Co., Ltd., Zoteis and Virbac Animal Health India Private Limited, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Flunixin Meglumine Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Flunixin Meglumine Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Flunixin Meglumine Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Flunixin Meglumine Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Flunixin Meglumine Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Flunixin Meglumine Injection sales, projected growth trends, production technology, application and end-user industry.

Flunixin Meglumine Injection Segment by Company

Wuhan Huisheng Biological Technology Co., Ltd.
Shandong Zhongmu Veterinary Medicine Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd.
Qilu Animal Health Products Co., Ltd.
Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
Hebei New Century Pharmaceutical Co., Ltd.
Baimukang Animal Pharmaceutical Co., Ltd.
Zoteis
Virbac Animal Health India Private Limited
Norbrook
MSD Animal Health
Merck Animal Health
Bengal Remedies Limited
Flunixin Meglumine Injection Segment by Type

10ml/Dose
20ml/ Dose
Flunixin Meglumine Injection Segment by Application

Animal muscle pain
Animal febrile disease
Others
Flunixin Meglumine Injection Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flunixin Meglumine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flunixin Meglumine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flunixin Meglumine Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Flunixin Meglumine Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flunixin Meglumine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Flunixin Meglumine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Flunixin Meglumine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Table of Contents

197 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Flunixin Meglumine Injection Market Size, 2020 VS 2024 VS 2031
1.3 Global Flunixin Meglumine Injection Market Size Estimates and Forecasts (2020-2031)
1.4 Global Flunixin Meglumine Injection Sales Estimates and Forecasts (2020-2031)
1.5 Global Flunixin Meglumine Injection Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Flunixin Meglumine Injection Market Dynamics
2.1 Flunixin Meglumine Injection Industry Trends
2.2 Flunixin Meglumine Injection Industry Drivers
2.3 Flunixin Meglumine Injection Industry Opportunities and Challenges
2.4 Flunixin Meglumine Injection Industry Restraints
3 Flunixin Meglumine Injection Market by Manufacturers
3.1 Global Flunixin Meglumine Injection Revenue by Manufacturers (2020-2025)
3.2 Global Flunixin Meglumine Injection Sales by Manufacturers (2020-2025)
3.3 Global Flunixin Meglumine Injection Average Sales Price by Manufacturers (2020-2025)
3.4 Global Flunixin Meglumine Injection Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Flunixin Meglumine Injection Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Flunixin Meglumine Injection Manufacturers, Product Type & Application
3.7 Global Flunixin Meglumine Injection Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Flunixin Meglumine Injection Market CR5 and HHI
3.8.2 Global Top 5 and 10 Flunixin Meglumine Injection Players Market Share by Revenue in 2024
3.8.3 2024 Flunixin Meglumine Injection Tier 1, Tier 2, and Tier 3
4 Flunixin Meglumine Injection Market by Type
4.1 Flunixin Meglumine Injection Type Introduction
4.1.1 10ml/Dose
4.1.2 20ml/ Dose
4.2 Global Flunixin Meglumine Injection Sales by Type
4.2.1 Global Flunixin Meglumine Injection Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Flunixin Meglumine Injection Sales by Type (2020-2031)
4.2.3 Global Flunixin Meglumine Injection Sales Market Share by Type (2020-2031)
4.3 Global Flunixin Meglumine Injection Revenue by Type
4.3.1 Global Flunixin Meglumine Injection Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Flunixin Meglumine Injection Revenue by Type (2020-2031)
4.3.3 Global Flunixin Meglumine Injection Revenue Market Share by Type (2020-2031)
5 Flunixin Meglumine Injection Market by Application
5.1 Flunixin Meglumine Injection Application Introduction
5.1.1 Animal muscle pain
5.1.2 Animal febrile disease
5.1.3 Others
5.2 Global Flunixin Meglumine Injection Sales by Application
5.2.1 Global Flunixin Meglumine Injection Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Flunixin Meglumine Injection Sales by Application (2020-2031)
5.2.3 Global Flunixin Meglumine Injection Sales Market Share by Application (2020-2031)
5.3 Global Flunixin Meglumine Injection Revenue by Application
5.3.1 Global Flunixin Meglumine Injection Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Flunixin Meglumine Injection Revenue by Application (2020-2031)
5.3.3 Global Flunixin Meglumine Injection Revenue Market Share by Application (2020-2031)
6 Global Flunixin Meglumine Injection Sales by Region
6.1 Global Flunixin Meglumine Injection Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Flunixin Meglumine Injection Sales by Region (2020-2031)
6.2.1 Global Flunixin Meglumine Injection Sales by Region (2020-2025)
6.2.2 Global Flunixin Meglumine Injection Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Flunixin Meglumine Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Flunixin Meglumine Injection Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Flunixin Meglumine Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Flunixin Meglumine Injection Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Flunixin Meglumine Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Flunixin Meglumine Injection Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Flunixin Meglumine Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Flunixin Meglumine Injection Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Flunixin Meglumine Injection Revenue by Region
7.1 Global Flunixin Meglumine Injection Revenue by Region
7.1.1 Global Flunixin Meglumine Injection Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Flunixin Meglumine Injection Revenue by Region (2020-2025)
7.1.3 Global Flunixin Meglumine Injection Revenue by Region (2026-2031)
7.1.4 Global Flunixin Meglumine Injection Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Flunixin Meglumine Injection Revenue (2020-2031)
7.2.2 North America Flunixin Meglumine Injection Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Flunixin Meglumine Injection Revenue (2020-2031)
7.3.2 Europe Flunixin Meglumine Injection Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Flunixin Meglumine Injection Revenue (2020-2031)
7.4.2 Asia-Pacific Flunixin Meglumine Injection Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Flunixin Meglumine Injection Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Flunixin Meglumine Injection Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Wuhan Huisheng Biological Technology Co., Ltd.
8.1.1 Wuhan Huisheng Biological Technology Co., Ltd. Comapny Information
8.1.2 Wuhan Huisheng Biological Technology Co., Ltd. Business Overview
8.1.3 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Portfolio
8.1.5 Wuhan Huisheng Biological Technology Co., Ltd. Recent Developments
8.2 Shandong Zhongmu Veterinary Medicine Co., Ltd.
8.2.1 Shandong Zhongmu Veterinary Medicine Co., Ltd. Comapny Information
8.2.2 Shandong Zhongmu Veterinary Medicine Co., Ltd. Business Overview
8.2.3 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Portfolio
8.2.5 Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Developments
8.3 Shandong Lukang Pharmaceutical Co., Ltd.
8.3.1 Shandong Lukang Pharmaceutical Co., Ltd. Comapny Information
8.3.2 Shandong Lukang Pharmaceutical Co., Ltd. Business Overview
8.3.3 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
8.3.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments
8.4 Qilu Animal Health Products Co., Ltd.
8.4.1 Qilu Animal Health Products Co., Ltd. Comapny Information
8.4.2 Qilu Animal Health Products Co., Ltd. Business Overview
8.4.3 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Portfolio
8.4.5 Qilu Animal Health Products Co., Ltd. Recent Developments
8.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
8.5.1 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Comapny Information
8.5.2 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Business Overview
8.5.3 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
8.5.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Developments
8.6 Hebei New Century Pharmaceutical Co., Ltd.
8.6.1 Hebei New Century Pharmaceutical Co., Ltd. Comapny Information
8.6.2 Hebei New Century Pharmaceutical Co., Ltd. Business Overview
8.6.3 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
8.6.5 Hebei New Century Pharmaceutical Co., Ltd. Recent Developments
8.7 Baimukang Animal Pharmaceutical Co., Ltd.
8.7.1 Baimukang Animal Pharmaceutical Co., Ltd. Comapny Information
8.7.2 Baimukang Animal Pharmaceutical Co., Ltd. Business Overview
8.7.3 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
8.7.5 Baimukang Animal Pharmaceutical Co., Ltd. Recent Developments
8.8 Zoteis
8.8.1 Zoteis Comapny Information
8.8.2 Zoteis Business Overview
8.8.3 Zoteis Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Zoteis Flunixin Meglumine Injection Product Portfolio
8.8.5 Zoteis Recent Developments
8.9 Virbac Animal Health India Private Limited
8.9.1 Virbac Animal Health India Private Limited Comapny Information
8.9.2 Virbac Animal Health India Private Limited Business Overview
8.9.3 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Portfolio
8.9.5 Virbac Animal Health India Private Limited Recent Developments
8.10 Norbrook
8.10.1 Norbrook Comapny Information
8.10.2 Norbrook Business Overview
8.10.3 Norbrook Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Norbrook Flunixin Meglumine Injection Product Portfolio
8.10.5 Norbrook Recent Developments
8.11 MSD Animal Health
8.11.1 MSD Animal Health Comapny Information
8.11.2 MSD Animal Health Business Overview
8.11.3 MSD Animal Health Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 MSD Animal Health Flunixin Meglumine Injection Product Portfolio
8.11.5 MSD Animal Health Recent Developments
8.12 Merck Animal Health
8.12.1 Merck Animal Health Comapny Information
8.12.2 Merck Animal Health Business Overview
8.12.3 Merck Animal Health Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Merck Animal Health Flunixin Meglumine Injection Product Portfolio
8.12.5 Merck Animal Health Recent Developments
8.13 Bengal Remedies Limited
8.13.1 Bengal Remedies Limited Comapny Information
8.13.2 Bengal Remedies Limited Business Overview
8.13.3 Bengal Remedies Limited Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Bengal Remedies Limited Flunixin Meglumine Injection Product Portfolio
8.13.5 Bengal Remedies Limited Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Flunixin Meglumine Injection Value Chain Analysis
9.1.1 Flunixin Meglumine Injection Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Flunixin Meglumine Injection Production Mode & Process
9.2 Flunixin Meglumine Injection Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Flunixin Meglumine Injection Distributors
9.2.3 Flunixin Meglumine Injection Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.